We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $114B Turnover 39.06%
1-Year Est. Return 35.47%
 

Marshall Wace is a British firm that runs long/short hedge funds. Its strategies combine computer-driven and traditional company analysis, applied worldwide and mostly to long/short equity. Paul Marshall, formerly head of European equities at Mercury Asset Management, and Ian Wace, formerly head of equities trading at Deutsche Bank, founded it in 1997. In 2002 it launched TOPS, a system that gathers investment ideas from equity professionals and uses algorithms to turn them into stock portfolios. In 2015 Marshall Wace formed a long-term partnership with KKR, a private equity and credit investor that took an ownership interest in the firm.

This Fund
S&P 500
This Quarter Est. Return
+7.07%
1 Year Est. Return
+35.47%
3 Year Est. Return
+152.69%
5 Year Est. Return
+193.17%
10 Year Est. Return
+740.37%
AUM
$7.57B
AUM Growth
+$643M
Cap. Flow
+$235M
Cap. Flow %
3.11%
Top 10 Hldgs %
16.13%
Holding
1,154
New
301
Increased
231
Reduced
236
Closed
370
Avg Time Held
0.4 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.4 years

Top Buys

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$71M
2
BAX icon
Baxter International
BAX
+$60.7M
3
TMUS icon
T-Mobile US
TMUS
+$60.1M
4
PRGO icon
Perrigo
PRGO
+$53.7M
5
NRG icon
NRG Energy
NRG
+$50.9M

Sector Composition

Rank Sector Weight
1 Healthcare 19.07%
2 Consumer Discretionary 12.28%
3 Industrials 12.1%
4 Technology 11.2%
5 Financials 10.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TMUS icon
1
T-Mobile US
TMUS
$175B
$232M 3.06%
8,597,767
+2,175,864
+34% +$60.1M
2013 Q2
6 quarters
ZTS icon
2
Zoetis
ZTS
$32.1B
$166M 2.19%
3,861,089
+56,173
+1% +$2.28M
2013 Q2
6 quarters
AZO icon
3
AutoZone
AZO
$52.4B
$140M 1.84%
225,623
+43,929
+24% +$24.8M
2013 Q2
6 quarters
EPI icon
4
WisdomTree India Earnings Fund ETF
EPI
$1.92B
$123M 1.63%
5,599,188
+430,848
+8% +$9.7M
2014 Q2
2 quarters
MU icon
5
Micron Technology
MU
$673B
$110M 1.46%
3,154,121
-632,102
-17% -$20.9M
2013 Q2
6 quarters
HPQ icon
6
HP
HPQ
$25.2B
$101M 1.34%
2,526,100
+388,369
+18% +$14.3M
2013 Q2
6 quarters
AAL icon
7
American Airlines Group
AAL
$7.89B
$87.9M 1.16%
1,639,590
-436,400
-21% -$18.8M
2014 Q1
3 quarters
PPG icon
8
PPG Industries
PPG
$25.9B
$87.8M 1.16%
759,502
+148,776
+24% +$15.4M
2013 Q2
6 quarters
PFE icon
9
Pfizer
PFE
$156B
$87.3M 1.15%
2,801,948
+1,336,415
+91% +$40.4M
2014 Q1
3 quarters
CMCSA icon
10
Comcast
CMCSA
$88.4B
$85.7M 1.13%
2,955,342
+262,796
+10% +$7.2M
2013 Q2
6 quarters
COF icon
11
Capital One
COF
$107B
$82M 1.08%
992,961
+398,350
+67% +$32.4M
2014 Q1
3 quarters
AGN
12
DELISTED
Allergan Inc
AGN
$79.1M 1.04%
372,011
+357,098
+2,395% +$71M
2014 Q1
3 quarters
FDX icon
13
FedEx
FDX
$71.2B
$77.5M 1.02%
446,076
+79,756
+22% +$13.5M
2013 Q2
6 quarters
PRGO icon
14
Perrigo
PRGO
$2.21B
$76.2M 1.01%
455,639
+343,186
+305% +$53.7M
2014 Q1
3 quarters
MOS icon
15
Mosaic
MOS
$5.93B
$75.1M 0.99%
1,644,884
+1,111,446
+208% +$49.3M
2013 Q2
6 quarters
CP icon
16
Canadian Pacific Kansas City
CP
$78.1B
$69.5M 0.92%
1,803,955
+717,065
+66% +$28.4M
2013 Q2
6 quarters
COO icon
17
Cooper Companies
COO
$11.2B
$69.1M 0.91%
1,705,152
-14,960
-0.9% -$600K
2014 Q1
3 quarters
UNP icon
18
Union Pacific
UNP
$171B
$67.8M 0.9%
569,177
+142,299
+33% +$16.3M
2013 Q2
6 quarters
LBTYK icon
19
Liberty Global Class C
LBTYK
$3.26B
$66.6M 0.88%
1,379,391
-766,517
-36% -$34.6M
2013 Q2
6 quarters
C icon
20
Citigroup
C
$183B
$66.6M 0.88%
1,230,501
+322,235
+35% +$17.1M
2013 Q2
6 quarters
BAX icon
21
Baxter International
BAX
$13.1B
$62M 0.82%
+846,191
New +$60.7M
2014 Q4
0 quarters
MON
22
DELISTED
Monsanto
MON
$54.4M 0.72%
455,739
+253,584
+125% +$29.5M
2013 Q2
6 quarters
HSY icon
23
Hershey
HSY
$35.3B
$53.7M 0.71%
516,346
+60,347
+13% +$5.88M
2013 Q2
6 quarters
AMSG
24
DELISTED
Amsurg
AMSG
$52.9M 0.7%
965,896
+792,242
+456% +$40.4M
2014 Q2
2 quarters
PKG icon
25
Packaging Corp of America
PKG
$20.9B
$52.5M 0.69%
672,958
+353,851
+111% +$25.4M
2014 Q1
3 quarters

Similar funds

Marshall Wace's Q4 2014 Portfolio in Review

As of Q4 2014, Marshall Wace held 1,154 positions worth $7.57B, up 9.3% from $6.93B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace deployed $235M of net new capital in Q4 2014, opening 301 new positions and adding to 231 existing holdings. Its largest new stake was Baxter International: 846,191 shares worth $62M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Alibaba, an estimated $68.2M trimmed.

  • Marshall Wace's largest Q4 2014 buy was Baxter International: 846,191 shares worth $62M.
  • Marshall Wace added most to Allergan Inc in Q4 2014, an estimated $71M increase.
  • Marshall Wace's biggest Q4 2014 reduction was Alibaba, cutting an estimated $68.2M.
  • Marshall Wace fully exited Baker Hughes in Q4 2014, selling an estimated $40.5M.
  • Marshall Wace's ten largest holdings make up 16% of its $7.57B portfolio in Q4 2014.
  • Marshall Wace opened 301 new positions and closed 370 in Q4 2014.
  • Marshall Wace's portfolio value rose 9.3% quarter-over-quarter to $7.57B.

Based on Marshall Wace's 13F filing for Q4 2014, filed 17 Feb 2015.